Mortality risks associated with empirical antibiotic activity in E. coli bacteraemia: an analysis of electronic health records

Mortality risks associated with empirical antibiotic activity in E. coli bacteraemia: an analysis of electronic health records

<p><strong>Background:</strong> Reported bacteraemia outcomes following inactive empirical antibiotics (based on in-vitro testing) are conflicting, potentially reflecting heterogeneity in causative species, MIC breakpoints defining resistance/susceptibility, and times to rescue the...

Descripció completa

Dades bibliogràfiques
Autors principals:	Yoon, CH, Bartlett, S, Stoesser, N, Pouwels, KB, Jones, N, Crook, D, Peto, TEA, Walker, AS, Eyre, DW
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2022

Ítems similars

Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.
per: Schlackow, I, et al.
Publicat: (2012)

The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study
per: Naylor, NR, et al.
Publicat: (2019)

Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection
per: Gu, Q, et al.
Publicat: (2024)

Hash-based core genome multilocus sequencing typing for Clostridium difficile
per: Eyre, DW, et al.
Publicat: (2019)

Does appropriate empiric antibiotic therapy modify intensive care unit-acquired Enterobacteriaceae bacteraemia mortality and discharge?
per: Pouwels, K, et al.
Publicat: (2017)

Hospital exposure in a UK population, and its association with bacteraemia.
per: Wyllie, D, et al.
Publicat: (2007)

Effect of COVID-19 vaccination on transmission of Alpha and Delta variants
per: Eyre, DW, et al.
Publicat: (2022)

Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia
per: Mark P. Khurana, et al.
Publicat: (2024-07-01)

Genomic surveillance of Escherichia coli and Klebsiella spp. in hospital sink drains and patients
per: Constantinides, B, et al.
Publicat: (2020)

Antimicrobial resistance genes and clonal success in Escherichia coli isolates causing bloodstream infection
per: Lipworth, S, et al.
Publicat: (2021)

Exploring uncatalogued genetic variation in antimicrobial resistance gene families in Escherichia coli, an observational analysis
per: Lipworth, S, et al.
Publicat: (2024)

Symptoms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in the general population in the United Kingdom
per: Vihta, K-D, et al.
Publicat: (2021)

Is MRSA admission bacteraemia community-acquired? A case control study.
per: Miller, R, et al.
Publicat: (2008)

Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.
per: Wyllie, D, et al.
Publicat: (2006)

Are there better methods of monitoring MRSA control than bacteraemia surveillance? An observational database study
per: Walker, S, et al.
Publicat: (2008)

Are there better methods of monitoring MRSA control than bacteraemia surveillance? An observational database study.
per: Walker, S, et al.
Publicat: (2008)

The quality of vital signs measurements and value preferences in electronic medical records varies by hospital, specialty, and patient demographics
per: Jackson, N, et al.
Publicat: (2023)

MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.
per: Wyllie, D, et al.
Publicat: (2005)

Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis
per: Yuan-Pin Hung, et al.
Publicat: (2022-05-01)

Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels
per: Gu, Q, et al.
Publicat: (2022)

Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar
per: Pritchard, E, et al.
Publicat: (2024)

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
per: Wei, J, et al.
Publicat: (2021)

The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study.
per: Nichola R Naylor, et al.
Publicat: (2019-01-01)

Are there better methods of monitoring MRSA control than bacteraemia surveillance? An observational database study.
per: Sarah Walker, et al.
Publicat: (2008-01-01)

Extensive within-host diversity in fecally carried extended-spectrum-beta-lactamase-producing Escherichia coli isolates: implications for transmission analyses
per: Stoesser, N, et al.
Publicat: (2015)

Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.
per: Fizpatrick, J, et al.
Publicat: (2015)

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
per: Pouwels, KB, et al.
Publicat: (2021)

Selection and co-selection of antibiotic resistances among Escherichia coli by antibiotic use in primary care: An ecological analysis
per: Pouwels, KB, et al.
Publicat: (2019)

Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data.
per: Stoesser, N, et al.
Publicat: (2013)

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
per: Eyre, DW, et al.
Publicat: (2021)

Awareness of appropriate antibiotic use in primary care for influenza-like illness: evidence of improvement from UK population-based surveys
per: Pouwels, KB, et al.
Publicat: (2020)

Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
per: Stoesser, N, et al.
Publicat: (2017)

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
per: Pritchard, E, et al.
Publicat: (2021)

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
per: Wei, J, et al.
Publicat: (2022)

Reducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear-based messages about antimicrobial resistance
per: Roope, L, et al.
Publicat: (2020)

Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections
per: Lipworth, SIW, et al.
Publicat: (2021)

Applications of whole genome sequencing to understanding the mechanisms, evolution and transmission of antibiotic resistance in Escherichia coli and Klebsiella pneumonia
per: Stoesser, N, et al.
Publicat: (2014)

Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance
per: Pritchard, E, et al.
Publicat: (2021)

Discordance between different bioinformatic methods for identifying resistance genes from short-read genomic data, with a focus on Escherichia coli
per: Davies, TJ, et al.
Publicat: (2023)

Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records
per: Vihta, K, et al.
Publicat: (2018)